BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11443849)

  • 21. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
    Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H
    Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and therapy of medullary thyroid carcinoma].
    Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
    [No Abstract]   [Full Text] [Related]  

  • 23. [Multiple endocrine neoplasia type 2a and 2b].
    Vestergaard P
    Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple endocrine neoplasia syndromes. Type 2].
    Juodele L; Juozaityte E; Zindzius A; Pundzius J
    Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 28. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
    Sarathi V; Bandgar TR; Menon PS; Shah NS
    Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unresolved issues in the genesis and management of multiple endocrine neoplasia type 2.
    Gagel RF
    Horm Metab Res; 1997 Mar; 29(3):135-7. PubMed ID: 9137984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II.
    Matias-Guiu X
    Adv Anat Pathol; 1998 May; 5(3):196-201. PubMed ID: 9868525
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple endocrine neoplasia type 2: clinical manifestations and management.
    Traugott AL; Moley JF
    Cancer Treat Res; 2010; 153():321-37. PubMed ID: 19957233
    [No Abstract]   [Full Text] [Related]  

  • 32. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
    Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
    Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and genetic screening of an extended family with MEN2A.
    Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
    J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of RET mutation analysis in multiple endocrine neoplasia type 2.
    Noll WW
    Arch Pathol Lab Med; 1999 Nov; 123(11):1047-9. PubMed ID: 10539905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Abdominal space-occupying lesion. Bilateral pheochromocytoma in MEN IIa and well differentiated retroperitoneal liposarcoma].
    Lohr F; Bahner ML; Raue F
    Radiologe; 1995 Aug; 35(8):543-5. PubMed ID: 7568803
    [No Abstract]   [Full Text] [Related]  

  • 39. Extrathyroidal manifestations of multiple endocrine neoplasia type 2.
    Brauckhoff M; Gimm O
    Thyroid; 2009 Jun; 19(6):555-7. PubMed ID: 19499988
    [No Abstract]   [Full Text] [Related]  

  • 40. Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA.
    Porpiglia F; Destefanis P; Bovio S; Allasino B; Orlandi F; Fontana D; Angeli A; Terzolo M
    Horm Res; 2002; 57(5-6):197-9. PubMed ID: 12053093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.